AzurRx BioPharma Inc Emerging Growth Conference Transcript

May 12, 2021 / 02:30PM GMT
Unidentified Analyst -

Welcome to the 7th Emerging Growth Conference. I am [Ana Berry.] It's been a great morning so far, and we have some fantastic presentations coming up for you today. Let's start with AzurRx Biopharma, Inc. It trades on the NASDAQ under the symbol AZRX and is a clinical stage biopharmaceutical company specializing in the development of targeted nonsystemic therapies for gastrointestinal diseases.

Joining us today, we have Martin Krusin, SVP of Corporate Development; and we have Dan Schneiderman, the CFO. Welcome, Martin.

Martin Krusin - AzurRx BioPharma, Inc. - SVP of Corporate Development

Ana. Pleasure to be here.

Unidentified Analyst -

Yes. We're happy to hear your presentation. So the floor is yours, whenever you're ready.

Martin Krusin - AzurRx BioPharma, Inc. - SVP of Corporate Development

Thank you very much, and thank you for having us participate in this year's Emerging Growth Conference. So we're a AzurRx Biopharma. And as Ana said, we are a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot